Paper · 41832306
FGF family in health and disease.
Liu X and 8 others. Mol Biomed, 2026. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. FGF family in health and disease. Papers, record 41832306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41832306
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factors | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Signal Transduction | |
| Homeostasis | |
| Humans | |
| Animals | |
| Metabolic Networks and Pathways | |
| Tyrosine Kinase Inhibitors |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JYZZ270 | School of Medicine, Shanghai Jiao Tong University | PubMed | ||
| 82071104 | National Natural Science Foundation of China | PubMed | ||
| 81570964 | National Natural Science Foundation of China | PubMed | ||
| 82100989 | National Natural Science Foundation of China | PubMed | ||
| 23XD1434200 | Science and Technology Commission of Shanghai Municipality | PubMed | ||
| 22Y21901000 | Science and Technology Commission of Shanghai Municipality | PubMed | ||
| SHDC12022120 | Shanghai Hospital Development Center | PubMed | ||
| NCRCO2021-omics-07 | National Clinical Research Center for Oral Diseases | PubMed | ||
| 19MC1910600 | Shanghai Clinical Research Center for Oral Diseases | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References414
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,501,574 | Mutations in different components of FGF signaling in LADD syndrome. | Nat Genet | 2006 | https://conductscience.org/library/papers/16501574 | PubMed |
| 2 | 26,903,404 | Regulation of FGF signaling: Recent insights from studying positive and negative modulators. | Semin Cell Dev Biol | 2016 | https://conductscience.org/library/papers/26903404 | PubMed |
| 3 | 11,276,432 | Fibroblast growth factors. | Genome Biol | 2001 | https://conductscience.org/library/papers/11276432 | PubMed |
| 4 | 20,084,103 | Kidney development in the absence of Gdnf and Spry1 requires Fgf10. | PLoS Genet | 2010 | https://conductscience.org/library/papers/20084103 | PubMed |
| 5 | 31,743,079 | Regulation and Effects of FGF23 in Chronic Kidney Disease. | Annu Rev Physiol | 2020 | https://conductscience.org/library/papers/31743079 | PubMed |
| 6 | 29,942,929 | Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease. | J Endocr Soc | 2018 | https://conductscience.org/library/papers/29942929 | PubMed |
| 7 | 19,802,384 | Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells. | PLoS One | 2009 | https://conductscience.org/library/papers/19802384 | PubMed |
| 8 | 40,258,390 | FGF1ΔHBS ameliorates DSS-induced ulcerative colitis by reducing neutrophil recruitment through the MAPK pathway. | Br J Pharmacol | 2025 | https://conductscience.org/library/papers/40258390 | PubMed |
| 9 | 11,031,111 | Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. | Genomics | 2000 | https://conductscience.org/library/papers/11031111 | PubMed |
| 10 | 24,733,629 | Isoforms of receptors of fibroblast growth factors. | J Cell Physiol | 2014 | https://conductscience.org/library/papers/24733629 | PubMed |
1 to 10 of 414
See all 414 referencesCited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,977,970 | FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications. | Biomark Res | 2026 | https://conductscience.org/library/papers/42977970 | PubMed |
| 42,957,849 | Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42957849 | PubMed |
| 42,883,713 | Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883713 | PubMed |
| 42,793,070 | State-Dependent FGF Signaling in Satellite Cell-Mediated Skeletal Muscle Regeneration and Pathological Remodeling. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793070 | PubMed |
| 42,724,301 | FGF18 aggravates angiotensin II-induced vascular smooth muscle cell dysfunction via the FGFR-ERK/AKT-GSK3β/β-catenin pathway. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42724301 | PubMed |
| 42,653,660 | Quince Gel Attenuates Experimental Ulcerative Colitis Through Antioxidant, Anti-Inflammatory and Mucosal Repair Mechanisms: Integrated Histopathological, Bioinformatic and Molecular Docking Analyses. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653660 | PubMed |
| 42,511,911 | The Role of FGF1 in Chronic Liver Diseases. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511911 | PubMed |
| 42,479,094 | Macrophage-derived FGF21 Restrains Endometritis By Suppressing Inflammation and Promoting Repair Through FGFR1. | Inflammation | 2026 | https://conductscience.org/library/papers/42479094 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| BAP1 | 8,314 | PubTator's text mining | https://conductscience.org/library/genes/8314 | NCBI Gene |
| CBL | 867 | PubTator's text mining | https://conductscience.org/library/genes/867 | NCBI Gene |
| DDIT3 | 1,649 | PubTator's text mining | https://conductscience.org/library/genes/1649 | NCBI Gene |
| EDNRA | 1,909 | PubTator's text mining | https://conductscience.org/library/genes/1909 | NCBI Gene |
| EIF2AK3 | 9,451 | PubTator's text mining | https://conductscience.org/library/genes/9451 | NCBI Gene |
| FGF1 | 2,246 | PubTator's text mining | https://conductscience.org/library/genes/2246 | NCBI Gene |
| FGF10 | 2,255 | PubTator's text mining | https://conductscience.org/library/genes/2255 | NCBI Gene |
| FGF13 | 2,258 | PubTator's text mining | https://conductscience.org/library/genes/2258 | NCBI Gene |
1 to 10 of 39
See all 39 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41832306
GET https://conductscience.org/api/papers/v1/41832306/references?page=2